AKT 1/2 inhibitor BAY1125976

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

AKT 1/2 inhibitor BAY1125976

An orally bioavailable inhibitor of the serine/threonine protein kinase AKT (protein kinase B) isoforms 1 and 2 (AKT1/2) with potential antineoplastic activity. AKT1/2 inhibitor BAY1125976 selectively binds to and inhibits the phosphorylation and activity of AKT1/2 in a non-ATP competitive manner, which may result in the inhibition of the phosphatidylinositol 3 (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway. This may lead to both the reduction of cell proliferation and the induction of cell apoptosis in AKT-overexpressing tumor cells. The AKT signaling pathway is often deregulated in cancer and is associated with tumor cell proliferation, survival and migration.

External links

Medicine icon
Medicine icon

This WikiMD article AKT 1/2 inhibitor BAY1125976 is a stub. If you are familiar with the topic AKT 1/2 inhibitor BAY1125976, you can help us. Paid editors welcome!


AKT 1/2 inhibitor BAY1125976 is part of WikiMD's free ^articles!

^AKT 1/2 inhibitor BAY1125976 (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available